GSK · 4 hours ago
Summer Intern/Vaccine Marketing
GSK is a global biopharma company focused on uniting science, technology, and talent to combat diseases. The Summer Intern in Vaccine Marketing will work on a project related to the US Flu Market, conducting situation analysis and competitive landscape assessments to inform the US flu strategy.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Assigned a US marketing project that supports the strategy or tactical execution of the VBU
Gather primary and secondary data and be responsible for making a recommendation regarding the US flu strategy
Qualification
Required
Pursuing a BS (Junior or Senior level) or Graduate degree in Business, Economics, or similar discipline
Must be able to work full-time (35-40 hours/week) throughout the duration of 12 week internship (May/June ~ August 2026)
Must have an active student status and/or within 12 months post-graduation from a BS or MS degree program. Post-doctoral candidates are not eligible
Knowledge of Microsoft Office applications (PowerPoint, Excel)
Strong verbal and written communication skills
Ability to work independently and in a team environment
Must successfully pass a drug screen and background check prior to assignment target start date
Completion of the immersive GSK Digital Assessment is required to proceed in the application process
Benefits
Relocation stipend
Competitive hourly pay rate
Benefits
Overtime pay
Company
GSK
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
H1B Sponsorship
GSK has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (45)
2024 (56)
2023 (54)
2022 (53)
2021 (54)
2020 (72)
Funding
Current Stage
Public CompanyTotal Funding
$25.51MKey Investors
CARB-X
2021-03-02Grant· $18M
2020-09-23Grant· $7.51M
1978-01-13IPO
Recent News
2026-01-16
2026-01-13
South China Morning Post
2026-01-08
Company data provided by crunchbase